Blue Horseshoe Stocks: NBEV Recap & More

New Age Beverages Corp. NBEV

It was back on the 9th of this month that we selected NBEV as a potential bottom play, and wanted to kick off the week by swinging back around to recap the excellent move the stock has made for us thus far.

After seeing a low of 2.11 on the morning of our initial alert, the stock has continually risen over the eight sessions since, touching a high of 4.24 on Friday. That represents a very nice 101% move, while volume over the same period has been notably increased. We’ll continue to monitor the progress here in coming sessions.


PetMed Express Inc. PETS

Speaking of steady risers, we’ve watched PETS for quite awhile now, having mentioned it for the first time in our report from the morning of September 11th.

Subsequent to that report, we observed a low of 32.90 and despite already being a thirty dollar stock, we’ve still seen it increase gradually and significantly, culminating at Friday’s high of 53.89. That marks a 64% increase, which is absolutely fantastic for a stock in this price range.

We’ll be interested to see how the stock is affected by the company’s solid premarket earnings release today. It’s gapping up in early trading and it appears we will see our observed highs boosted yet again.


Extended Watchlist:
ATEN, ARRY, LTBR, NINE, LFIN, ACST

Blue Horseshoe Stocks: ALDX Review & More

Aldeyra Therapeutics, Inc. ALDX

The big standout from yesterday morning’s premarket report turned out to be ALDX, which initially drew our attention with an abnormal volume signal, and the release of positive Phase 2a study data for a Dry Eye Disease treatment.

The stock recorded a continuously bullish pattern throughout the day, trading in an impressive range. From it’s early morning low of 6.60, the stock reached a high of 11.05 just prior to the closing bell. That’s an increase 67% on the day, on more than twenty times the monthly average volume. It also easily took the top gainer spot on the NASDAQ board for the session.

ALDX increasing in value by two-thirds in a single session worked well for us yesterday, but such moves also rare and often unsustainable events. It’s difficult to imagine a scenario where the stock doesn’t undergo a consolidation in the session or sessions to come.


Macy’s, Inc. M – Options Review

We want to swing back around for a recap of the performance in a set of Macy’s calls we made a few weeks ago as a longer-term options idea. Typically, when a stock seems set for an extended rebound, we’ll signal contracts whose expiration doesn’t occur for a longer period of time. In this case we highlighted the

It worked out nicely, with M stock making a steady increase over these last few weeks that facilitated a move in those calls from .60-1.37, which comes out to a respectable gain of 128%

______

Fresh Idea:

We also look for quick strike chances as well, and may have one with Mirati Therapeutics, Inc. MRTX today after the stock soared following the presentation of positive cancer trial data at a conference in Chicago.

We’ll be looking for a dip-and-rip pattern off of this morning’s significant premarket gap-up, and will be tracking the MRTX Weekly $7.50 Calls* and possibly even the $10’s if it appears as if MRTX wants to break that ten dollar barrier.

*Never attempt to trade weekly options on a Friday unless you are A.) An expert trader and B.) Have money you can afford to lose. It’s an extremely risky proposition.


Extended Watchlist:
LPTH, ARRY, MBOT, ATOS, RXII

Blue Horseshoe Stocks: SFOR Update & More

StrikeForce Technologies, Inc. SFOR

Prior to including it in yesterday morning’s premarket report, our next most recent mentions of SFOR were last Wednesday and Thursday, giving all our readers plenty of time to catch the massive wave of momentum that has now carried the stock to new highs.

At that time we observed a low of .008 in the stock and in the ensuing four sessions it has managed to register higher highs and higher lows each day. The intraday range on the stock yesterday alone was .0134-.022, a solid 64% rip. Measured from last week’s low, we’ve now witnessed an overall upswing of 175% From our all-time observed low on this familiar play (.0036), yesterday’s high marked a 511% jump.

We’ll continue to observe for an extension of the pattern that has been established here, and remain interested as long as the stock maintains support above yesterday’s swing low.


Oroplata Resources, Inc. ORRP

We signaled ORRP for observation in yesterday’s watchlist, and the stock ended up making a really nice run into the close that was good for sizable intraday gains.

We noticed this one in a routine morning scan yesterday, however, as it is a stock that’s been heavily promoted in the past, we’d like to take this opportunity that our interest in it was purely fundamental. We are not connected in any way to any of the promotions/promoters that have ever gone out on this stock.

In terms of the move it made subsequent to yesterday’s mention, we saw ORRP traverse its way from .265 to .405, for a healthy intraday gain of 53% The stock closed just a shade below its high of day, so we’ll certainly be on the lookout for a continuation of momentum into today’s session.


Acorda Therapeutics, Inc. ACOR

The confluence of a newly-recorded annual low, some insider selling, and a sizable gap to the on the chart to the upside have us thinking about a longer-term options idea to correspond with a possible recovery.

The chart still appears to gearing down, so we could see some slight downside before this idea comes to fruition, but we want to signal and begin monitoring now to make sure we’re not late to the party

. We’re going to put a tab on the ACOR 10/18 $23-25 Calls to prepare ourselves for what could be quite a significant rebound once the stock finds a solid level of support from which to launch a rebound.


Extended Watchlist:
GNID, SGBY, PIRS, ARRY, ATNM, NAVB,